Stephen Bloch is a General Partner of Canaan Partners, a premier global venture capital firm founded in 1987 with more than $3 billion under management. Dr. Bloch draws on his experience in medicine, government and business to invest in areas of healthcare that promise to change how medicine is practiced.
Some of his investments include Advanced BioHealing, Amicus Therapeutics, Axial Exchange, Cylex, Dicom Grid, Liquidia Technologies, and Marinus Pharmaceuticals. Prior to joining Canaan, he founded Radiology Management Sciences, a pioneer in managing radiology benefits for health plans. In addition, he helped start OmniSonics Medical Technologies, which engineered novel ultrasonic catheters for treating vascular occlusive disease and co-founded TeleRad, an early teleradiology services company.
Dr. Bloch received his medical training at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine). He earned his medical degree from the University of Rochester, a master’s degree in the history of science and public policy from Harvard University, and an A.B. degree from Dartmouth College.
For more than three decades, Carter Morse & Goodrich has excelled at maximizing shareholder value for our clients and leading transactions through to successful completion.
Please enter your information below to receive email updates from Carter Morse & Goodrich.